Literature DB >> 10764709

Analysis of genetic and phenotypic heterogeneity in juvenile polyposis.

K Woodford-Richens1, S Bevan, M Churchman, B Dowling, D Jones, C G Norbury, S V Hodgson, D Desai, K Neale, R K Phillips, J Young, B Leggett, M Dunlop, P Rozen, C Eng, D Markie, M A Rodriguez-Bigas, E Sheridan, T Iwama, D Eccles, G T Smith, J C Kim, K M Kim, J R Sampson, G Evans, S Tejpar, W F Bodmer, I P Tomlinson, R S Houlston.   

Abstract

BACKGROUND: Juvenile polyposis syndrome (JPS) is characterised by gastrointestinal (GI) hamartomatous polyposis and an increased risk of GI malignancy. Juvenile polyps also occur in the Cowden (CS), Bannayan-Ruvalcaba-Riley (BRRS) and Gorlin (GS) syndromes. Diagnosing JPS can be problematic because it relies on exclusion of CS, BRRS, and GS. Germline mutations in the PTCH, PTEN and DPC4 (SMAD4) genes can cause GS, CS/BRRS, and JPS, respectively. AIMS: To examine the contribution of mutations in PTCH, PTEN, and DPC4 (SMAD4) to JPS.
METHODS: Forty seven individuals from 15 families and nine apparently sporadic cases with JPS were screened for germline mutations in DPC4, PTEN, and PTCH.
RESULTS: No patient had a mutation in PTEN or PTCH. Five different germline mutations were detected in DPC4; three of these were deletions, one a single base substitution creating a stop codon, and one a missense change. None of these patients had distinguishing clinical features.
CONCLUSIONS: Mutations in PTEN and PTCH are unlikely to cause juvenile polyposis in the absence of clinical features indicative of CS, BRRS, or GS. A proportion of JPS patients harbour DPC4 mutations (21% in this study) but there remains uncharacterized genetic heterogeneity in JPS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764709      PMCID: PMC1727907          DOI: 10.1136/gut.46.5.656

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome.

Authors:  D J Marsh; P L Dahia; Z Zheng; D Liaw; R Parsons; R J Gorlin; C Eng
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

2.  Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

Authors:  H Tashiro; M S Blazes; R Wu; K R Cho; S Bose; S I Wang; J Li; R Parsons; L H Ellenson
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

3.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident.

Authors:  C Wicking; S Shanley; I Smyth; S Gillies; K Negus; S Graham; G Suthers; N Haites; M Edwards; B Wainwright; G Chenevix-Trench
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

5.  A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria.

Authors:  R F Jacoby; S Schlack; C E Cole; M Skarbek; C Harris; L F Meisner
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

6.  Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.

Authors:  E M Arch; B K Goodman; R A Van Wesep; D Liaw; K Clarke; R Parsons; V A McKusick; M T Geraghty
Journal:  Am J Med Genet       Date:  1997-09-05

7.  Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

Authors:  P Guldberg; P thor Straten; A Birck; V Ahrenkiel; A F Kirkin; J Zeuthen
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

8.  Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.

Authors:  E Rhei; L Kang; F Bogomolniy; M G Federici; P I Borgen; J Boyd
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

9.  Clinical and molecular features of the hereditary mixed polyposis syndrome.

Authors:  S C Whitelaw; V A Murday; I P Tomlinson; H J Thomas; S Cottrell; A Ginsberg; S Bukofzer; S V Hodgson; R B Skudowitz; J R Jass; I C Talbot; J M Northover; W F Bodmer; E Solomon
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

10.  PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

Authors:  B K Rasheed; T T Stenzel; R E McLendon; R Parsons; A H Friedman; H S Friedman; D D Bigner; S H Bigner
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

View more
  26 in total

1.  Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation.

Authors:  Changqing Ma; Francis M Giardiello; Elizabeth A Montgomery
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

2.  SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome.

Authors:  Danielle Langeveld; W Arnout van Hattem; Wendy W J de Leng; Folkert H Morsink; Fiebo J W Ten Kate; Francis M Giardiello; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Clin Cancer Res       Date:  2010-08-03       Impact factor: 12.531

Review 3.  Malignant tumors associated with juvenile polyposis syndrome in Japan.

Authors:  Hideyuki Ishida; Keiichiro Ishibashi; Takeo Iwama
Journal:  Surg Today       Date:  2017-05-26       Impact factor: 2.549

4.  Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.

Authors:  X P Zhou; K Woodford-Richens; R Lehtonen; K Kurose; M Aldred; H Hampel; V Launonen; S Virta; R Pilarski; R Salovaara; W F Bodmer; B A Conrad; M Dunlop; S V Hodgson; T Iwama; H Järvinen; I Kellokumpu; J C Kim; B Leggett; D Markie; J P Mecklin; K Neale; R Phillips; J Piris; P Rozen; R S Houlston; L A Aaltonen; I P Tomlinson; C Eng
Journal:  Am J Hum Genet       Date:  2001-08-30       Impact factor: 11.025

5.  An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features.

Authors:  Paul Rozen; Ziona Samuel; Eli Brazowski; Markus Jakubowicz; Jacob Rattan; Zamir Halpern
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

6.  The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.

Authors:  J R Howe; M G Sayed; A F Ahmed; J Ringold; J Larsen-Haidle; A Merg; F A Mitros; C A Vaccaro; G M Petersen; F M Giardiello; S T Tinley; L A Aaltonen; H T Lynch
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

7.  An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.

Authors:  E E M Jaeger; K L Woodford-Richens; M Lockett; A J Rowan; E J Sawyer; K Heinimann; P Rozen; V A Murday; S C Whitelaw; A Ginsberg; W S Atkin; H T Lynch; M C Southey; H Debinski; C Eng; W F Bodmer; I C Talbot; S V Hodgson; H J W Thomas; I P M Tomlinson
Journal:  Am J Hum Genet       Date:  2003-04-14       Impact factor: 11.025

Review 8.  Pathology of the hereditary colorectal carcinoma.

Authors:  Zoran Gatalica; Emina Torlakovic
Journal:  Fam Cancer       Date:  2007-06-13       Impact factor: 2.375

9.  Prophylactic total gastrectomy in the management of hereditary tumor syndromes.

Authors:  Dimitrios Pantelis; Robert Hüneburg; Ronja Adam; Stefanie Holzapfel; Heidrun Gevensleben; Jacob Nattermann; Christian P Strassburg; Stefan Aretz; Jörg C Kalff
Journal:  Int J Colorectal Dis       Date:  2016-09-28       Impact factor: 2.571

Review 10.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.